Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 241 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
| TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2022-04-21 | 2023-06-21 | 159201 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-23 | 224898 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2017-03-15 | 2017-12-15 | 2986 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2019-12-19 | 2020-01-25 | 101707 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2024-04-18 | 2024-05-23 | 225477 |
| TEVA-EMTEC-30 | 300MG 30MG | TABLET | Resolved | 2021-02-18 | 2021-03-04 | 134346 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194180 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-16 | 2023-08-17 | 195072 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3121 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2019-12-12 | 2020-01-25 | 101145 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118928 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125458 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-10-31 | 2020-07-23 | 97594 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |